New Jersey Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 17 (71% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 10,331
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 54.82%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 575
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 43.10%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 37.88% 47.30%
White, Hispanic/Latino Patients 19.24% 17.74%
Black/African American, Non-Hispanic/Latino Patients 14.38% 9.57%
Black/African American, Hispanic/Latino Patients 3.10% 2.43%
Asian Patients3 0.82% 0.52%
American Indian/Alaska Native Patients3 1.00% 1.39%
Native Hawaiian/Other Pacific Islander Patients3 0.45% 0.52%
Patients with More than one race3 4.62% 1.91%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.34% 1.74%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.06% 2.61%
Unreported/Refused to Report Race and Ethnicity 13.12% 14.26%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,602
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 79.62%
COVID-19 Immunization Series Completed 2,519
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 81.62%
COVID-19 Immunization Series Additional 251
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 40.51%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 17.98% 15.92% 46.22%
White, Hispanic/Latino Patients 38.83% 36.36% 18.33%
Black/African American, Non-Hispanic/Latino Patients 16.79% 15.40% 3.19%
Black/African American, Hispanic/Latino Patients 2.50% 1.87% 2.39%
Asian Patients3 1.12% 2.58% 2.79%
American Indian/Alaska Native Patients3 2.37% 3.97% 0.40%
Native Hawaiian/Other Pacific Islander Patients3 0.19% 1.19% 1.59%
Patients with More than one race3 2.56% 2.70% 0.40%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 5.87% 6.63% 2.39%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 4.74% 5.12% 4.78%
Unreported/Refused to Report Race and Ethnicity 7.05% 8.26% 17.53%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 0.00%
1 to 24 Hours 23.53%
More Than 24 Hours 76.47%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 11.76%
Staffing to administer the vaccine 23.53%
Vaccine confidence 47.06%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 23.53%
None 17.65%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 75.88%
Average Percent of Health Center Visits Conducted Virtually 16.47%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 47.06%
Number of Mobile Van Sites 11
Number of Pop-up Clinics 29
Number of School-Based Vaccination Sites 5

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 5.88%
Refer patients to another organization that provides monoclonal antibody therapies 41.18%
None 52.94%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 11.76%
Patient awareness/education 11.76%
Staffing capacity 17.65%
Therapy administration/onsite logistics 29.41%
Other 0.00%
None 47.06%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021